NDC 70518-1237-00 - VENTOLIN HFA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-1237
- Requested NDC
- 70518-1237-00
- Package NDCs from labels
- 70518-1237-0, 70518-1237-00
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-01-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| VENTOLIN HFA - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-01-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-1237-0 | VENTOLINHFA | 60 in 1 INHALER | AEROSOL, METERED | 60 | 13 | |
| 70518-1237-0 | VENTOLINHFA | 1 in 1 CARTON | AEROSOL, METERED | 1 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-1237 | VENTOLIN HFA (ALBUTEROL SULFATE) AEROSOL, METERED [REMEDYREPACK INC.] | 12 | Current NDC, Legacy NDC, 2 package rows | 20250509_2ed73618-be3a-4331-9509-6401258f791f.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ipratropium Bromide and Albuterol Sulfate | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Nephron Pharmaceuticals Corporation | ae35ec1f-526a-49bf-8262-c50e40190d1f | 2025-04-08 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Proficient Rx LP | a6545fbe-b0a6-41ae-8bb6-91af38410f56 | 2025-04-01 | Warnings, Adverse reactions | 021SEF3731 |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | Chartwell RX, LLC | 560df50c-e2c4-459f-9d89-bf7e6588949e | 2025-03-28 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Nephron Pharmaceuticals Corporation | ecc00500-58b8-491f-80df-dc6c89a08cae | 2025-03-21 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol | ALBUTEROL | Rising Pharma Holdings, Inc. | 40f3cdbc-c9ee-4a3c-8061-a44b9a1d035c | 2025-03-06 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | NuCare Pharmaceuticals,Inc. | 813d49be-3651-6759-e053-2991aa0a6a9f | 2025-02-06 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol sulfate | ALBUTEROL SULFATE | Lupin Pharmaceuticals, Inc. | 973b8686-c6ce-4280-85c4-c1e7ceab3c09 | 2025-01-23 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol sulfate | ALBUTEROL SULFATE | A-S Medication Solutions | 52e209ac-7156-4496-ba5a-42ee59d45deb | 2025-01-22 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | NuCare Pharmaceuticals,Inc. | 749992b4-69e0-0cc8-e053-2991aa0aeb25 | 2025-01-08 | Warnings, Adverse reactions | 021SEF3731 |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | HF Acquisition Co LLC, DBA HealthFirst | 9d4ef83f-8ca0-811e-e053-2995a90a6d0d | 2025-01-08 | Warnings, Adverse reactions | 021SEF3731 |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | Preferred Pharmaceuticals, Inc. | 4aafc2dd-744d-4726-828f-70355aee6f70 | 2025-01-03 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Proficient Rx LP | 53eecdef-a7ff-4ca3-a313-d4b9c29c898d | 2025-01-01 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate HFA | ALBUTEROL SULFATE | Advanced Rx of Tennessee, LLC | 04c8a345-0a0d-5a01-e063-6294a90a40d2 | 2024-12-31 | Warnings, Adverse reactions | NDA020983 2123076 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Advanced Rx Pharmacy of Tennessee, LLC | f44b325d-0f74-552c-e053-2995a90ac1c9 | 2024-12-31 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate Inhalation | ALBUTEROL SULFATE | Amneal Pharmaceuticals NY LLC | 2e449282-ee58-4e36-b983-85c4e6f0864d | 2024-12-20 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol | ALBUTEROL | Zydus Lifesciences Limited | a4709eea-e4a2-46e2-850f-1e6afca01893 | 2024-11-25 | 021SEF3731 | |
| Albuterol Sulfate | ALBUTEROL SULFATE | Ingenus Pharmaceuticals, LLC | e14f5fd6-d01a-489d-9baa-61778b1352a8 | 2024-10-22 | Warnings, Adverse reactions | 021SEF3731 |
| albuterol sulfate | ALBUTEROL SULFATE | Padagis Israel Pharmaceuticals Ltd | 489201d2-9ed0-419b-81dc-a7f7f86b59ed | 2024-09-30 | Warnings, Adverse reactions | 021SEF3731 |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | Bryant Ranch Prepack | 45e07bdd-78f9-4055-9de3-646e67de7eaf | 2024-08-15 | Warnings, Adverse reactions | 021SEF3731 |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. | 1d6be2b8-c670-b783-e063-6294a90ae503 | 2024-07-31 | Warnings, Adverse reactions | 021SEF3731 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.